More on ATYR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+61.5% Growth)
- Ratings (3.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

aTyr Pharma (NQ:ATYR)
Delayed: 0.48 --0 (-0%)
Prev. Close $0.48  
Open$0.48 
52 Wk High$ 
52 Wk Low$ 
Day High$0.48 
Day Low$0.48 
P/E N/A  
EPS$ 
Volume27,919 

Friends, Peers and Foes (?): ABBV, ARVN, ASND, BBIO, BCAX (more...)

Sep 1, 2026 04:39 PM aTyr Pharma expects FDA response on Phase 3 sarcoidosis trial by mid-Sept
Aug 10, 2026 06:00 AM aTyr Pharma, Inc. (ATYR) Tops Q2 EPS by 1c
Aug 7, 2026 04:11 PM Form S-8 aTYR PHARMA INC
Aug 7, 2026 04:08 PM Form 10-Q aTYR PHARMA INC For: Jun 30
Aug 7, 2026 04:05 PM Form 8-K aTYR PHARMA INC For: Aug 07
Aug 7, 2026 04:01 PM aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
Aug 6, 2026 10:15 AM Form SCHEDULE 13G/A aTYR PHARMA INC Filed by: FMR LLC
Jul 31, 2026 04:45 PM Form 8-K aTYR PHARMA INC For: Jul 30
Jul 27, 2026 04:27 PM Form SCHEDULE 13G/A aTYR PHARMA INC Filed by: BlackRock, Inc.
Jul 15, 2026 08:00 AM aTyr Pharma to present efzofitimod subgroup data at WASOG 2026
View All Articles

Entities mentioned with ATYR

View All Entities